EMR vs GEV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 26, 2026

EMR

65.1
AI Score
VS
EMR Wins

GEV

57.4
AI Score

Investment Advisor Scores

EMR

Jan 26, 2026
65score
Recommendation
BUY

GEV

Jan 26, 2026
57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR GEV Winner
Forward P/E 22.8833 52.0833 EMR
PEG Ratio 2.2877 1.7385 GEV
Revenue Growth 5.1% 11.8% GEV
Earnings Growth -35.3% -60.0% EMR
Tradestie Score 65.1/100 57.4/100 EMR
Profit Margin 12.7% 4.5% EMR
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY HOLD EMR

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.